Form 4: Aspira Women's Health Director, Stefanie L. Cavanaugh, Reports Acquisition and Disposal of Common Stock

Director Stefanie L. Cavanaugh reports acquisition of 16,804 shares and disposal of 54,976 shares of Aspira Women's Health Inc. common stock on August 12, 2024, following vesting of restricted stock units.

Summary

• Stefanie L. Cavanaugh, a director of Aspira Women's Health Inc., filed a Form 4 with the SEC.
• The form reports transactions involving the company's common stock on August 12, 2024.
• Cavanaugh acquired 16,804 shares of common stock through the vesting of restricted stock units, each convertible to one share.
• The restricted stock units vested fully on August 12, 2024.
• Cavanaugh also disposed of 54,976 shares.
• Following these transactions, Cavanaugh beneficially owns 54,976 shares of Aspira Women's Health Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company directors as an indicator of confidence in the company's prospects.

Key Dates

Keywords

Form 4, Aspira Women's Health, Director, Stefanie Cavanaugh, Stock Transaction, Beneficial Ownership, Restricted Stock Units, AWH